OncoArendi Therapeutics - Announcement of the result of tender procedure No. 34/2021-DUBs

OBJECT FOR THE REQUEST: In vitro safety studies for pharmaceutical safety evaluation within 5 months from the signing of the agreement.

After collecting all the information regarding the request for proposal and after analyzing the completeness of the offers, the Commission concludes that the most advantageous offer meeting all the requirements contained in the request has presented:

Eurofins Cerep SA, Le Bois I'Eveque 86600 Celle I'Evescault, France

Total net price of the order execution: 98 115,00 EUR (448 738,76 PLN)

The Commission recommends the Management Board to perform the order in accordance with the offer submitted by this Contractor.

Contact:

Chemical Laboratory in Lodz

OncoArendi Therapeutics SA

Dowborczykow 30/34, 90-019 od

Mobile: [phone]

E: [e-mail]

(C) 2021 Electronic News Publishing, source ENP Newswire